Treatment of IBD Flashcards
Mechanism of 5-ASA in IBD
Inhibit synthesis of prostaglandins and inflammatory leukotrienes and cytokines
Inhibits activity of NFkB
First line agents for mild to moderate UC, used to induce and maintain remission
5-ASA compounds
First line therapy for mild to moderate Crohn’s involving the colon and/or distal ileum
5-ASA compounds
Generic name for 5-ASA used for IBD
Mesalmine
Compounds containing 5-ASA
Sulfasalazine
Olsalazine
Balsalazine
Side effect associated with high dose 5-ASA compound
Renal tubular damage
Drug used in pts with moderate to severe IBD, to induce treatment and treat flares
Glucocorticoids
Purine antimetabolites used to treat IBD
Azathioprine
6-mercaptopurine
Drug class used to induce and maintain remission of IBD in pts who depend on long-term glucocorticoid therapy
Purine antimetabolites
Adverse effects of purine antimetabolites
Bone marrow suppression
Hepatic toxicity
Lymphoma risk with long-term use
Specific lab value to check before initiating therapy with purine antimetabolites and why
Thiopurine methyltransferase (TPMT)
Low TPMT associated with increased leukopenia risk
DHFR inhibitor used to induce and maintain remission in Crohn’s
Methotrexate
Adverse effects of methotrexate
Bone marrow suppression
Megaloblastic anemia
Alopecia
Mucositis
Anti-TNF drugs used in IBD
Infliximab
Adalimumab
Golimumab
Certolizumab